2,234
Views
19
CrossRef citations to date
0
Altmetric
Original Articles

Formulation development and evaluation of the anti-malaria properties of sustained release artesunate-loaded solid lipid microparticles based on phytolipids

, , , &
Pages 652-665 | Accepted 07 Jan 2014, Published online: 30 Jan 2014

References

  • Attama AA, Muller-Goymann CC. (2006). A critical study of novel physically structured lipid matrices composed of a homolipid from Capra hircus and theobroma oil. Int J Pharm 322:67–78
  • Attama AA, Muller-Goymann CC. (2007). Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid. Int J Pharm 334:179–89
  • Attama AA, Nkemnele MO. (2005). In vitro evaluation of drug release from self micro-emulsifying drug delivery systems using a biodegradable homolipid from Capra hircus. Int J Pharm 304:4–10
  • Attama AA, Okafor CE, Builders PF, Okorie O. (2009). Formulation and in vitro evaluation of a PEGylated microscopic lipospheres delivery system for ceftriaxone sodium. Drug Deliv 16:448–616
  • Attama AA, Schicke BC, Müller-Goymann CC. (2006). Further characterization of theobroma oil beeswax admixtures as lipid matrices for improved drug delivery systems. Eur J Pharm Biopharm 64:294–306
  • Aulton ME. (1999). Pharmaceutics: the science of dosage form design. Edinburgh, London, New York, Philadelphia, Sydney Toronto: International Student Edition, 94
  • Boistelle R, Astier JP. (1988). Crystallization mechanisms in solution. J Cryst Growth 90:14–30
  • Bouwstra JA, Gooris GS, Salomons-de vries MA, et al. (1992). Structure of human stratum corneum as a function of temperature and hydration: A wide-angle X-ray diffraction study. Int J Pharm 84:205–16
  • Brown SA, Chime SA, Attama AA, et al. (2013). In vitro and in vivo characterisation of piroxicam-loaded dika wax lipospheres. Trop J Pharm Res 12:33–8
  • Chime SA, Attama AA, Agubata CO, et al. (2012). Micromeritic and antinociceptive properties of lyophilized indomethacin-loaded SLMs based on solidified reverse micellar solutions. J Pharm Res 5:3410–16
  • Chime SA, Attama AA, Builders PF, Onunkwo GC. (2013a). Sustained release diclofenac potassium-loaded solid lipid microparticle, based on solidified reverse micellar solution (SRMS): In vitro and in vivo evaluation. J Microencapsul 30:335–45
  • Chime SA, Onunkwo GC, Onyishi IV. (2013b). Kinetics and mechanisms of drug release from swellable and non swellable matrices: a review. Res J Pharm Bio Chem Sc 4:97–103
  • Chadha R, Gupta S, Pathak N. (2012). Artesunate-loaded chitosan/lecithin nanoparticles: preparation, characterization, and in vivo studies. Drug Dev Ind Pharm 38:1538–46
  • Dikasso D, Makonnen E, Debella A, et al. (2006). In vivo anti-malaria activity of hydroalcoholic extract from Asparaginus africanus in mice infected with Plasmodium berghei. Ethiop J Health Dev 20:112–18
  • El-Kamel HA, Al–Fagih MI, Alsarra AI. (2007). Testosterone solid lipid microparticles for transdermal drug delivery formulation and physicochemical characterisation. J Microencapsul 24:457–75
  • Higuchi T. (1663). Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145–9
  • Hou DZ, Xie CS, Huang K, Zhu CH. (2003). The production and characteristics of solid lipid nanoparticles (SLN). Biomaterials 24:1781–5
  • Jaspart S, Piel G, Delatte L, Evrad B. (2005). Solid lipid microparticles: Formulation, preparation, characterization, drug release and applications. Expert Opin Drug Deliv 2:75–87
  • Kim DA, Cornec M, Narsimhan G. (2005). Effect of thermal treatment on interfacial properties of beta-lactoglobulin. J Colloid Interface Sci 285:100–9
  • Li Q, Weina P. (2010). Artesunate: The best drug in the treatment of severe and complicated malaria. Pharmaceuticals 3:2322–32
  • Liu K. (1999). Soybean: chemistry, technology, and utilization. : Aspen Publishers, Inc
  • Matos L, Nzikou JM, Pandzou–Yembe VN, et al. (2009). Studies of Irvingia gabonensis seed kernels: Oil technological applications. Pak J Nutri 8:151–7
  • Meara ML, Patel CB. (2006). The components acids and glycerides of dika wax. J Agric Food 12:40–57
  • Moghimi HR, Williams AC, Barry BW. (1996). A lamellar matrix model for stratum corneum intercellular lipids.1: Characterization and comparison with stratum corneum intercellular structure. Int J Pharm 131:103–15
  • Obitte NC, Chime SA, Magaret AA, et al. (2012). Some in vitro and pharmacodynamic evaluation of indomethacin solid lipid microparticles. Afr J Pharm Pharmacol 6:2309–17
  • Obitte NC, Chime SA, Attama AA, et al. (2013). Evaluation of the pharmacodynamic properties of indomethacin-loaded lipospheres. Int Res J Pharm Pharmacol 3:77–84
  • Ofoefule SI, Chukwu A, Okore VC, Ugwah MO. (1997). Use of dika fat in the formulation of sustained release frusemide encapsulated granules. Boll Chim Farm 136:646–50
  • Okore VC. (2000). Effect of dika fat content of a barrier film coating on the kinetics of drug release from swelling polymeric systems. Boll Chim Farm 139:21–5
  • Peters W, Robinson BL, Torey G, et al. (1993). The chemotherapy of rodent malaria 1. The activities of some synthetic I, 2, 4-trioxanes against chloroquine-sensitive and chloroquine resistant parasite, part 3: observations Fenozan-5oF a di-fluorated 3,3-spirocyclopentane1, 2,4-trioxane. Annals Trop Med Parasitol 87:111–23
  • Pilaniya K, Pilaniya U, Saharan S, et al. (2011). Biodegradable solid lipid microparticles loaded with diltiazem hydrochloride for oral delivery: preparation and in vitro/in vivo evaluation. J Drug Del Ther 1:48–59
  • Ponts N, Harris EY, Jacques P, et al. (2010). Nucleosome landscape and control of transcription in the human malaria parasite. Genome Res 20:, 228–38
  • Rawat SM, Singh D, Saraf S. (2011). Formulation optimization of controlled delivery systems for antihypertensive peptides using response surface methodology. Am J Drug Dis Dev 1:174–87
  • Reithmeier HJ, Herrmann J, Gopferich A. (2001). Development and characterisation of lipid microparticles as a drug carrier for somatostatin. Int J Pharm 218:133–43
  • Ritger PL, Peppas NA. (1987). A simple equation for description of solute release 1. Fickian and non- Fickian release from non swellable device in the form of slabs, spheres, cylinders and discs. J Cont Rel 1987:5:23–36
  • Sanna V, Kirschvink N, Gustin P, et al. (2004). Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS Pharm Sci Technol 5:e27: 17–23
  • Shapiro TA, Goldberg DA. (2006). Analgesic-antipyretic and anti-inflammatory agents; pharmacotherapy of gout. In: Goodman and Gilman’s the pharmacological basis of therapeutics, 11th Edition. USA: McGraw-Hill Medical Publishing Division, 1021-7
  • Singh J, Gupta S, Kaur H. (2011). Prediction of in vitro drug release mechanisms from extended release matrix tablet using SSR/SR2 techniques. Trends App Sci Res 6:400–9
  • Tiemi-Shio M, Eisenbarth SC, Savaria M, et al. (2009). Malarial Hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog 5,e1000559:1–14
  • Umeyor EC, Kenechukwu FC, Ogbonna JD, et al. (2012). Preparation of novel solid lipid microparticles loaded with gentamicin and its evaluation in vitro and in vivo. J Microencapsul 29:296–307
  • Vivek K, Reddy H, Murthy RS. (2007). Investigation of the effect of the lipid matrix on drug entrappement, in vitro release and physical stability of olanzepine-loaded solid lipid nanoparticles. AAPS PharmSciTech 8,83:E1–E9
  • WHO. (2009). World Malaria Report. World Health Organization: Geneva, Switzerland. 21 February 2010. Available online: http://www.who.int/malaria/publications/atoz/9789241563901/en/index.html/ [last accessed 21 Jul 2010]
  • You J, Cui F, Zi Q, et al. (2005). A novel formulation design about water insoluble oily drug: Preparation of Zedoaryl tumeric oil microspheres with self emulsifying ability and evaluation in rabbits. Int J Pharm 288:315–23

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.